Artificial intelligence predicts gestational diabetes in Chinese women

December 22, 2020

WASHINGTON--Machine learning, a form of artificial intelligence, can predict which women are at high risk of developing gestational diabetes and lead to earlier intervention, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Gestational diabetes is a common complication during pregnancy that affects up to 15 percent of pregnant women. High blood sugar in the mother can be dangerous for the baby and lead to complications like stillbirth and premature delivery. Most women are diagnosed with gestational diabetes during the second trimester, but some women are at high risk and could benefit from earlier intervention.

"Our study leveraged artificial intelligence to predict gestational diabetes in the first trimester using electronic health record data from a Chinese hospital," said study author He-Feng Huang Ph.D. of the Shanghai Jiao Tong University School of Medicine and the International Peace Maternity and Child Health Hospital in Shanghai, China. "These findings can help clinicians identify women at high risk of diabetes in early pregnancy and start interventions such as diet changes sooner. The artificial intelligence technology will continue to improve over time and help us better understand the risk factors for gestational diabetes."

The researchers analyzed nearly 17,000 electronic health records from a hospital in China in 2017 with machine learning models to predict women at high risk for gestational diabetes. They compared their predictions with 2018 electronic health record data and found they were successful at identifying who would develop gestational diabetes. The prediction models also found an association between low body mass and gestational diabetes.
-end-
Other authors of the study include: Yan-Ting Wu, Chen-Jie Zhang, Cheng Li, Yu Wang, Jian-Xia Fan, and Lei Chen of the Shanghai Jiao Tong University School of Medicine and the International Peace Maternity and Child Health Hospital; Ben Willem Mol and Andrew Kawai of Monash University in Melbourne, Australia; Jian-Zhong Sheng of the Zhejiang University in Zhejiang, China; and Yi Shi of the Shanghai Jiao Tong University.

The manuscript received funding from the National Key Research and Development Program of China, the National Natural Science Foundation of China, the Foundation of Shanghai Municipal Commission of Health and Family Planning, the Clinical Skills Improvement Foundation of Shanghai Jiaotong University School of Medicine, the Natural Science Foundation of Shanghai, the Shanghai Shenkang Hospital Development Center, Clinical Technology Innovation Project, the Program of Shanghai Academic Research Leader, the CAMS Innovation Fund for Medical Sciences, and the Outstanding Youth Medical Talents of Shanghai Rising Stars of Medical Talent Youth Development Program.

The manuscript, "Early Prediction of Gestational Diabetes Mellitus in the Chinese Population Via Advanced Machine Learning," was published online, ahead of print.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.